MONTREAL, CANADA -- (Marketwired) -- 08/31/15 -- Theratechnologies Inc. (TSX: TH) is pleased to announce that it has concluded an agreement with BL&H Co., LTD (BL&H) for the distribution and commercialization of EGRIFTA (tesamorelin for injection) for the treatment of HIV-associated lipod ...
↧